# Predictive Value of a Rectal Swab With Detection of Enterobacteria (ESBL-E), Carbapenemases, and High-level Cephalosporinase (HLC) on the Risk of Infections With C3G-resistant Enterobacteria

> **NCT07345923** · — · RECRUITING · sponsor: **University Hospital, Strasbourg, France** · enrollment: 1000 (estimated)

## Conditions studied

- Infections, Enterobacteriaceae

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07345923
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-06
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07345923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07345923, "Predictive Value of a Rectal Swab With Detection of Enterobacteria (ESBL-E), Carbapenemases, and High-level Cephalosporinase (HLC) on the Risk of Infections With C3G-resistant Enterobacteria". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07345923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*